Full name
MED-ORAL - SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.23.Z - Dental practice
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.19.Z - Retail trade
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2 | 2,3 | 2,8 | 20 |
EBITDA | 1,9 | 2,3 | 2,9 | 28,1 |
Short time liabilities | 0,8 | 0,9 | 0,6 | -29,4 |
Equity capital | 6,4 | 7,1 | 9,4 | 32,3 |
Operating profit (EBIT) | 1,8 | 2 | 2,6 | 26,3 |
Assets | 7,6 | 8 | 10 | 24,9 |
Net profit (loss) | 1,6 | 1,8 | 2,8 | 54,3 |
Cash | 1,6 | 1,5 | 4,3 | 176,1 |
Net income from sale | 9 | 11,5 | 12,7 | 10,4 |
Liabilities and provisions for liabilities | 1,2 | 0,9 | 0,6 | -32,8 |
Working assets | 1,7 | 2,3 | 4,5 | 92,5 |
Depreciation | 0,2 | 0,2 | 0,3 | 43,4 |
% | % | % | p.p. | |
Profitability of capital | 25,5 | 25,5 | 29,7 | 4,2 |
Equity capital to total assets | 84,4 | 88,7 | 93,9 | 5,2 |
Gross profit margin | 21,9 | 20,3 | 22 | 1,7 |
EBITDA Margin | 21,3 | 19,7 | 22,9 | 3,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 34 | 27 | 18 | -9 |
Current financial liquidity indicator | 2.07582950592041 | 2.6766440868377686 | 7.3036017417907715 | 4,6 |
Net dept to EBITDA | -0.5544856190681458 | -0.6633639931678772 | -1.4705785512924194 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane